Your browser doesn't support javascript.
loading
Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 Years.
Steiner, Normann; Schober, Paula; Willenbacher, Wolfgang; Kircher, Brigitte; Gunsilius, Eberhard; Wolf, Dominik; Nachbaur, David.
Afiliación
  • Steiner N; Department of Internal Medicine V (Hematology and Medical Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria normann.steiner@i-med.ac.at.
  • Schober P; Department of Internal Medicine V (Hematology and Medical Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Willenbacher W; Department of Internal Medicine V (Hematology and Medical Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Kircher B; Department of Internal Medicine V (Hematology and Medical Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Gunsilius E; Department of Internal Medicine V (Hematology and Medical Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Wolf D; Department of Internal Medicine V (Hematology and Medical Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Nachbaur D; Department of Internal Medicine V (Hematology and Medical Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
Anticancer Res ; 42(12): 5825-5832, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36456157
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Anticancer Res Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Anticancer Res Año: 2022 Tipo del documento: Article